Name | COX-2-IN-23 |
---|
Description | COX-2-IN-23 (compound 9a) is a selective COX-2 inhibitor with IC50 values of 0.28 and 20.14 μM for COX-2 and COX-1. COX-2-IN-23 has anti-inflammatory activity and low ulcerogenic activity. |
---|---|
Related Catalog | |
Target |
COX-2:0.28 μM (IC50) COX-1:20.14 μM (IC50) |
In Vivo | COX-2-IN-23 (compound 9a) (9 mg/kg; a single i.p.; 0-4 hours) exhibits anti-inflammatory activities and lowest incidence of pepticulcer[1]. Animal Model: Mature male albino rats[1] Dosage: 9 mg/kg Administration: Intraperitoneal injection; 0, 1, 2, 3 and 4 hours. Result: Had similar ulcerogenic activity to celecoxib. |
References |
Molecular Formula | C24H25N5O3S2 |
---|---|
Molecular Weight | 495.62 |